SavedAdd your journal

Journals / Tüberküloz ve Toraks / 2013 / Cilt: 61 - Sayı: 3

Investigation of CCL1 rs159294 T/A gene polymorphism in pulmonary and extrapulmonary tuberculosis patients

Pulmoner ve ekstrapulmoner tüberküloz hastalarında CCL1 rs159294 T/A gen polimorfizminin araştırılması

Vahit KONAR
Funda BULUT
Ebru ŞENLİ KARA
Deniz EROL
Hüseyin YÜCE
Figen DEVECİ
Fethi Ahmet ÖZDEMİR
Pages
200–208
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

And in control group, among 160 healthy individuals, TT genotype was found in 100 (62.5%) individuals, TA genotype was found in 58 (36.3%) individuals, AA genotype was found in 2 (1.3%) individuals and no statistically significant difference was found.Conclusion: CCL1 rs159294 T/A polymorphism do not form an inclination to tuberculosis in our population

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: The purpose of this study is to reveal whether CCL1 rs159294 T/A polymorphism in pulmonary and extrapulmonary tuberculosis patients pose a risk to catch tuberculosis or not.Materials and Methods: In the study, peripheral blood samples from the control group, which includes 160 patients, who consulted to Fırat University Faculty of Medicine, Pulmonology Policlinic in Elazığ province and who were diagnosed with tuberculosis; and 160 healthy individuals, were taken and put into tubes containing EDTA.
📊
Key Findings & Data:Each tube contained 2 cc blood samples.
💡
Conclusion & Impact:And in control group, among 160 healthy individuals, TT genotype was found in 100 (62.5%) individuals, TA genotype was found in 58 (36.3%) individuals, AA genotype was found in 2 (1.3%) individuals and no statistically significant difference was found.Conclusion: CCL1 rs159294 T/A polymorphism do not form an inclination to tuberculosis in our population
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: The purpose of this study is to reveal whether CCL1 rs159294 T/A polymorphism in pulmonary and extrapulmonary tuberculosis patients pose a risk to catch tuberculosis or not.Materials and Methods: In the study, peripheral blood samples from the control group, which includes 160 patients, who consulted to Fırat University Faculty of Medicine, Pulmonology Policlinic in Elazığ province and who were diagnosed with tuberculosis; and 160 healthy individuals, were taken and put into tubes containing EDTA. Each tube contained 2 cc blood samples. DNA isolation was made from these blood samples and CCL1 rs159294 T/A polymorphism was defined with PCR-RFLP analysis.Results: For CCL1 rs159294 T/A polymorphism, TT genotype was found in 98 (61.3%) patients, TA genotype was found in 58 (36.3%) patients, AA genotype was found in 4 (2.5%) patients among 160 patients with tuberculosis; and TT genotype was found in 50 (70.4%) patients, TA genotype in 20 (28.2%) patients, AA genotype was found in 1 (1.4%) patient among 71 patients with pulmonary tuberculosis; TT genotype was found in 48 (53.9%) patients TA genotype was found in 38 (42.7%) patients and AA genotype was found in 3 (3.4%) patients among 89 extrapulmonary tuberculosis patients. And in control group, among 160 healthy individuals, TT genotype was found in 100 (62.5%) individuals, TA genotype was found in 58 (36.3%) individuals, AA genotype was found in 2 (1.3%) individuals and no statistically significant difference was found.Conclusion: CCL1 rs159294 T/A polymorphism do not form an inclination to tuberculosis in our population

Özet

Giriş: Bu çalışmada amaç, pulmoner ve ekstrapulmoner tüberküloz hastalarındaki, CCL1 rs159294 T/A polimorfizminin tüberküloza yakalanma riski oluşturup oluşturmadığını ortaya koymaktır.Materyal ve Metod: Çalışmamızda Elazığ ili yöresinde Fırat Üniversitesi Tıp Fakültesi Göğüs Hastalıkları Polikliniğine başvuran, tüberküloz teşhisi konulmuş 160 hasta ve 160 sağlıklı bireyden oluşan kontrol grubuna ait kişilerden periferal kan örnekleri alınarak EDTA içeren tüplere 2 cc olacak şekilde konulmuştur. Bu kan örneklerinden DNA izolasyonu gerçekleştirilerek CCL1 rs159294 T/A polimorfizmi PCR-RFLP analizi yapılarak belirlenmiştir.Bulgular: CCL1 rs159294 T/A polimorfizmi için 160 tüberkülozlu hastanın 98 (%61.3)'inde TT genotipi, 58 (%36.3)'inde TA genotipi, 4 (%2.5)'ünde de AA genotipi, 71 pulmoner tüberkülozlu hastanın 50 (%70.4)'sinde TT genotipi, 20 (%28.2)'sinde TA genotipi, 1 (%1.4)'inde de AA genotipi, 89 ekstrapulmoner tüberkülozlu hastanın 48 (%53.9)'inde TT genotipi, 38 (%42.7)'inde TA genotipi, 3 (%3.4)'ünde de AA genotipi tespit edilmiştir. Kontrol grubunda ise 160 sağlıklı bireyin 100 (%62.5)'ünde TT genotipi, 58 (%36.3)'inde TA genotipi, 2 (%1.3)'sinde de AA genotipi belirlenmiş olup, istatistiksel olarak anlamlı bir farklılık saptanamamıştır.

🔖

Cite This Article

KONAR, V., BULUT, F., KARA, E. Ş., EROL, D., YÜCE, H., DEVECİ, F., ÖZDEMİR, F. A. (2022). Investigation of CCL1 rs159294 T/A gene polymorphism in pulmonary and extrapulmonary tuberculosis patients. Tüberküloz ve Toraks, Cilt: 61 - Sayı: 3, 200–208. https://ajindex.com/articles/618647

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Deligezer U, Akışık EE, Dalay N. The application of the lightcycller fluoresecence PCR in polymorphism analysis, Investigation of the Mthfr C677T polymorphism in childhood and adult patients with myeloid leukemia. Türk Onkoloji Dergisi 2004; 19: 4. Casanova J, Abel LL. Genetic dissection of immunity to mycobacteria the human model. Annu Rev Immunol 2002; 20: 581-620.
  2. Cooke GS, Hill AV. Genetics of susceptibility to human infectious disease. Nat Rev Genet 2001; 2: 77-967.
  3. Crevel R, Ottenhoff TH, Meer JW. Innate immunity to mycobacterium tuberculosis. Clin Microbiol Rev 2002; 15: 294-309.
  4. Bottasso O, Bay ML, Basedovsky H. The immuno endocrine component in the pathogenesisof tuberculosis. Scand J Immunol 2007; 66: 166-75.
  5. Srinivasan V, Maestroni GJ, Cardinali DP, Esquifino AI, Perumal SR, Miller SC. Melatonin immune function and aging. Immun Ageing 2005; 29: 17-29.
  6. Yıldırım A, Bardakçı F, Karataş M, Tanyolaç B. Moleküler Biyoloji. Ankara: Nobel Yayıncılık, 2007: 48. Nomiyama H, Mera A, Ohneda O, Miura R, Suda T, Yashie O. Organization of the chemokine genes in the human and mouse major clusters of CC and CXC Chemokines diversification between the two specios. Genes and Ummunity 2001; 2: 110-3.
  7. Sironi M, Martinez FO, Ambrosio DD. Differentid regulation of chemokine production by Fcg receptor engagement in human monocytes. Journal of Leukocyte Biology 2006; 80: 342-9.
  8. Ono SJ, Nakamura T, Miyazaki D. Chemokines roles in leukocyte development, trafficking, effector function. Biogen Inc 2003; 45: 168-77.
  9. Le Y, Hou Y, Iribarren P, Wong JM. Chemokines and chemokine receptors: their manifold roles in homeostasis and disease. Molecular Immunology 2004; 1: 95-104.
  10. Zhu XW, Friedland SJ. Multinucleate giant cells and the control of chemokine secretion in response to Mycobacterium tuberculosis. Clinical Immunology 2006; 120: 10-20. Özbal Y. Tuberculosis immunology. Erciyes Medical Journal 2006; 28: 25-34.
  11. Zhang ZH, Chen F, Zhang XL, Jin Y, Bai J, Fu SB. PTPN22 allelepolymorphisms in 15 chinese populations. Int J Immunogenet 2008; 35: 433-40.
  12. Widdison S, Watson M, Piercy J, Howard C, Coffey TJ. Granulocyte chemotactic properties of M. tuberculosis versus M. bovis infected bovine alveolar macrophages. Molecular Immunology 2007; 45: 740-9.
  13. Thuong NTT, Dunstan S, Chau TTH, Thorsson V, Simmons CP, Quyen NTH, et al. Identification of tuberculosis susceptibility genes with human macrophage gene expression profiles. PLOS Pathogens 2008; 4: 1-13.
  14. Takabatake N, Shibata Y, Abe S, Wa